Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Sell
37,946
-216,214
-85% -$1.43M ﹤0.01% 1931
2026
Q1
$1.32M Buy
254,160
+15,126
+6% +$94.7K ﹤0.01% 1212
2025
Q4
$1.75M Buy
239,034
+202,016
+546% +$1.96M ﹤0.01% 1185
2025
Q3
$480K Sell
37,018
-9,972
-21% -$110K ﹤0.01% 1344
2025
Q2
$457K Sell
46,990
-213,521
-82% -$1.39M ﹤0.01% 1397
2025
Q1
$1.51M Sell
260,511
-8,482
-3% -$75.5K ﹤0.01% 1225
2024
Q4
$2.88M Buy
268,993
+210,622
+361% +$1.85M ﹤0.01% 1097
2024
Q3
$603K Sell
58,371
-2,487
-4% -$25.8K ﹤0.01% 1394
2024
Q2
$814K Sell
60,858
-411,191
-87% -$3.44M ﹤0.01% 1249
2024
Q1
$2.48M Sell
472,049
-43,914
-9% -$381K ﹤0.01% 1106
2023
Q4
$5.57M Sell
515,963
-125,786
-20% -$1.24M ﹤0.01% 960
2023
Q3
$5.72M Sell
641,749
-15,419
-2% -$220K ﹤0.01% 951
2023
Q2
$10.8M Buy
657,168
+186,096
+40% +$2.16M 0.01% 832
2023
Q1
$5.31M Buy
471,072
+4,654
+1% +$38.2K ﹤0.01% 982
2022
Q4
$3.52M Buy
466,418
+327,148
+235% +$4.03M ﹤0.01% 1082
2022
Q3
$2.42M Buy
139,270
+126,668
+1,005% +$1.87M ﹤0.01% 1118
2022
Q2
$106K Buy
+12,602
New +$119K ﹤0.01% 1438

Other funds holding ENVX

Amundi's ENVX Position: Q2 2026 in Review

Amundi reduced its Enovix (ENVX) stake by 85% in Q2 2026, selling an estimated $1.43M and leaving 37,946 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1931.

Amundi first reported a position in ENVX in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.8M in Q2 2023. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • Amundi held 37,946 shares of Enovix worth $230K as of Q2 2026.
  • Amundi sold 216,214 Enovix shares in Q2 2026, an estimated $1.43M.
  • Enovix made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1931 holding.
  • Amundi first reported a position in Enovix in Q2 2022 and has held it in 17 quarters since.
  • Amundi's Enovix position peaked at $10.8M in Q2 2023.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.